microRNA-9 attenuates amyloidβ-induced synaptotoxicity by targeting calcium/calmodulin-dependent protein kinase kinase 2

Molecular Medicine Reports

Volumn 9, Issue 5, 2014, Pages 1917-1922

  Chang, Fei ^a   Zhang, Lin Hong ^a   Xu, W U Ping ^a   Jing, Ping ^a   Zhan, Pei Yan ^a  

^a CENTRAL HOSPITAL OF WUHAN   (China)

Author keywords

Adenosine monophosphate activated protein kinase; Alzheimer's disease; Amyloid ; Calcium calmodulin dependent protein kinase kinase 2; MicroRNA 9; Synapse

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE 2; MICRORNA 9; OLIGOMER; UNCLASSIFIED DRUG;

ALGORITHM; ANIMAL CELL; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DENDRITIC SPINE; GENE OVEREXPRESSION; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SYNAPTOTOXICITY; TOXICITY; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMP-ACTIVATED PROTEIN KINASES; AMYLOID BETA-PEPTIDES; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; MICE; MICRORNAS; NEURONS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; RNA INTERFERENCE; RNA, MESSENGER; SYNAPSES;

EID: 84899573857     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2013     Document Type: Article

References (37)

1. Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A and Polleux F: The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through tau phosphorylation. Neuron 78: 94-108, 2013.
2. Wang JZ and Liu F: Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 85: 148-175, 2008.
3. Vanitallie TB: Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention. Metabolism 62 (Suppl 1): S30-S33, 2013.
4. Wang JF, Lu R and Wang YZ: Regulation of β cleavage of amyloid precursor protein. Neurosci Bull 26: 417-427, 2010.
5. Jin M, Shepardson N, Yang T, Chen G, Walsh D and Selkoe DJ: Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci USA 108: 5819-5824, 2011.
6. Palop JJ, Chin J, Roberson ED, et al: Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55: 697-711, 2007.
7. Yuan HX, Xiong Y and Guan KL: Nutrient sensing, metabolism, and cell growth control. Mol Cell 49: 379-387, 2013.
8. Nakano A and Takashima S: LKB1 and AMP-activated protein kinase: regulators of cell polarity. Genes Cells 17: 737-747, 2012.
9. Salminen A, Kaarniranta K, Haapasalo A, Soininen H and Hiltunen M: AMP-activated protein kinase: a potential player in Alzheimer's disease. J Neurochem 118: 460-474, 2011.
10. Park H, Kam TI, Kim Y, et al: Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Hum Mol Genet 21: 2725-2737, 2012.
11. Kim J, Park YJ, Jang Y and Kwon YH: AMPK activation inhibits apoptosis and tau hyperphosphorylation mediated by palmitate in SH-SY5Y cells. Brain Res 1418: 42-51, 2011.
12. Vingtdeux V, Davies P, Dickson DW and Marambaud P: AMPK is abnormally activated in tangle-and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathol 121: 337-349, 2011.
13. Fernandez-Hernando C, Ramírez CM, Goedeke L and Suárez Y: MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 33: 178-185, 2013.
14. Delay C, Mandemakers W and Hebert SS: MicroRNAs in Alzheimer's disease. Neurobiol Dis 46: 285-290, 2012.
15. Hébert SS, Horré K, Nicolaï L, et al: Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 105: 6415-6420, 2008.
16. Leucht C, Stigloher C, Wizenmann A, Klafke R, Folchert A and Bally-Cuif L: MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary. Nat Neurosci 11: 641-648, 2008.
17. Schonrock N, Humphreys DT, Preiss T and Götz J: Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β. J Mol Neurosci 46: 324-335, 2012.
18. Schonrock N, Ke YD, Humphreys D, et al: Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One 5: e11070, 2010.
19. Zhu LQ, Zheng HY, Peng CX, et al: Protein phosphatase 2A facilitates axonogenesis by dephosphorylating CRMP2. J Neurosci 30: 3839-3848, 2010.
20. Rencurel F, Foretz M, Kaufmann MR, et al: Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol Pharmacol 70: 1925-1934, 2006.
21. Handoko M, Grant M, Kuskowski M, et al: Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults. JAMA Neurol 5: 594-599, 2013.
22. Gao L, Tian S, Gao H and Xu Y: Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice. J Mol Neurosci 51: 128-147, 2013.
23. Seward ME, Swanson E, Norambuena A, et al: Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease. J Cell Sci 126: 1278-1286, 2013.
24. Thornton C, Bright NJ, Sastre M, Muckett PJ and Carling D: AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure. Biochem J 434: 503-512, 2011.
25. Yoshida H and Goedert M: Phosphorylation of microtubule-associated protein tau by AMPK-related kinases. J Neurochem 120: 165-176, 2012.
26. Moolman DL, Vitolo OV, Vonsattel JP and Shelanski ML: Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol 33: 377-387, 2004.
27. Manczak M and Reddy PH: Abnormal interaction of oligomeric amyloid-β with phosphorylated tau: implications to synaptic dysfunction and neuronal damage. J Alzheimers Dis 36: 285-295, 2013.
28. Viollet B, Lantier L, Devin-Leclerc J, et al: Targeting the AMPK pathway for the treatment of Type 2 diabetes. Front Biosci (Landmark Ed) 14: 3380-3400, 2009.
29. Cai Z, Yan LJ, Li K, Quazi SH and Zhao B: Roles of AMP-activated protein kinase in Alzheimer's disease. Neuromolecular Med 14: 1-14, 2012.
30. Lu J, Wu DM, Zheng YL, et al: Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. J Pathol 222: 199-212, 2010.
31. Lukiw WJ: Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18: 297-300, 2007.
32. Ai J, Sun LH, Che H, et al: MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats. J Neurosci 33: 3989-4001, 2013.
33. Boissonneault V, Plante I, Rivest S and Provost P: MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 284: 1971-1981, 2009.
34. Liu W, Liu C, Zhu J, et al: MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice. Neurobiol Aging 33: 522-534, 2012.
35. Hébert SS, Horré K, Nicolaï L, et al: MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 33: 422-428, 2009.
36. Cogswell JP, Ward J, Taylor IA, et al: Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14: 27-41, 2008.
37. Tan SL, Ohtsuka T, González A and Kageyama R: MicroRNA9 regulates neural stem cell differentiation by controlling Hes1 expression dynamics in the developing brain. Genes Cells 17: 952-961, 2012.